Essential components of an effective transition from paediatric to adult neurologist care for adolescents with Duchenne muscular dystrophy; a consensus derived using the Delphi methodology in Eastern Europe, Greece and Israel
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Essential components of an effective transition from paediatric to adult neurologist care for adolescents with Duchenne muscular dystrophy; a consensus derived using the Delphi methodology in Eastern Europe, Greece and Israel ; volume:19 ; number:1 ; day:9 ; month:7 ; year:2024 ; pages:1-13 ; date:12.2024
Orphanet journal of rare diseases ; 19, Heft 1 (9.7.2024), 1-13, 12.2024
- Urheber
-
Molnar, Maria Judit
Szabó, Léna
Vladacenco, Oana Aurelia
Cobzaru, Ana Maria
Dor, Talya
Dori, Amir
Papadimas, Georgios
Juříková, Lenka
Litvinenko, Ivan
Tournev, Ivailo
Dixon, Craig
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13023-024-03270-2
- URN
-
urn:nbn:de:101:1-2409262134543.212223043467
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Molnar, Maria Judit
- Szabó, Léna
- Vladacenco, Oana Aurelia
- Cobzaru, Ana Maria
- Dor, Talya
- Dori, Amir
- Papadimas, Georgios
- Juříková, Lenka
- Litvinenko, Ivan
- Tournev, Ivailo
- Dixon, Craig
- SpringerLink (Online service)
Ähnliche Objekte (12)
Survival in Duchenne muscular dystrophy
Targeting angiogenesis in Duchenne muscular dystrophy
Pain characterization in Duchenne muscular dystrophy
Cognition trajectory in Duchenne muscular dystrophy
Vascular-targeted therapies for Duchenne muscular dystrophy
The Duchenne muscular dystrophy gene and cancer
Left ventricular noncompaction in Duchenne muscular dystrophy
Strategies for molecular therapy of Duchenne muscular dystrophy
Left ventricular T2 distribution in Duchenne Muscular Dystrophy
Improving clinical trial design for Duchenne muscular dystrophy
Left ventricular T2 distribution in Duchenne Muscular Dystrophy
Presence of mechanical dyssynchrony in duchenne muscular dystrophy
Survival in Duchenne muscular dystrophy
Targeting angiogenesis in Duchenne muscular dystrophy
Pain characterization in Duchenne muscular dystrophy
Cognition trajectory in Duchenne muscular dystrophy
Vascular-targeted therapies for Duchenne muscular dystrophy
The Duchenne muscular dystrophy gene and cancer
Left ventricular noncompaction in Duchenne muscular dystrophy
Strategies for molecular therapy of Duchenne muscular dystrophy
Left ventricular T2 distribution in Duchenne Muscular Dystrophy
Improving clinical trial design for Duchenne muscular dystrophy
Left ventricular T2 distribution in Duchenne Muscular Dystrophy
Presence of mechanical dyssynchrony in duchenne muscular dystrophy
Survival in Duchenne muscular dystrophy
Targeting angiogenesis in Duchenne muscular dystrophy
Pain characterization in Duchenne muscular dystrophy
Cognition trajectory in Duchenne muscular dystrophy
Vascular-targeted therapies for Duchenne muscular dystrophy
The Duchenne muscular dystrophy gene and cancer
Left ventricular noncompaction in Duchenne muscular dystrophy
Strategies for molecular therapy of Duchenne muscular dystrophy
Left ventricular T2 distribution in Duchenne Muscular Dystrophy
Improving clinical trial design for Duchenne muscular dystrophy
Left ventricular T2 distribution in Duchenne Muscular Dystrophy